Search for: "BRISTOL-MYERS SQUIBB" Results 681 - 700 of 863
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jun 2017, 4:14 am by Edith Roberts
At The Washington Legal Foundation’s Legal Pulse blog, Richard Samp discusses Bristol-Myers Squibb Co. v. [read post]
7 Feb 2017, 11:58 am by Clay Hodges
In 2015, Bristol-Myers Squibb Company paid $18.8 million to physicians relating to the sale and/or promotion of Eliquis. [read post]
2 Jun 2010, 3:15 am by Scott A. McKeown
Bristol-Myers Squibb Co., 326 F.3d at 1241; see Molins PLC, 48 F.3d at 1182 (“We recognize that [the withheld references] were cited eventually to the PTO and that the examiner . . . passed the reexamination application to issue thereafter. [read post]
15 Oct 2008, 8:38 am
AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas, GlaxoSmithKline, Bristol Myers Squibb, Johnson & Johnson, Novartis, Merck, and 3M.Less than six months after… [read post]
1 Jul 2009, 7:14 am
(Patent Docs) Products Avapro (Irbesartan) – Spain: Fourth Commercial Court of Barcelona rejects preliminary injunction petition by Sanofi-Aventis and Bristol-Myers Squibb for alleged patent infringement (International Law Office) Cozaar/Hyzaar (Losartan/Hydrochlorothiazide and Losartan) –US: Teva sues FDA over generic Cozaar and Hyzaar 180-day exclusivity forfeiture and patent delisting rule (The FDA Law Blog) Eloxatin (Oxaliplatin) – US:… [read post]
24 Sep 2017, 2:22 pm by Nancy E. Halpern, D.V.M.
., Professor and IACUC Chair, Rutgers University Elizabeth Dodemaide, BVSc, MA, MANZCVS, Director Comparative Medicine Resources, Rutgers University Gregory Reinhard, DVM, Director, Animal Welfare, University of Pennsylvania Strategies to Enhance Animal Welfare Compliance Monitoring Presenters: Pharmaceutical: Lisa Stanislawczyk, Bristol-Myers Squibb, CRO: Mary Ann Jacobs, Envigo Academic: Greg Reinhard, MBA, DVM, University of Pennsylvania, The Role of the Statistician… [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the… [read post]
8 Mar 2012, 3:34 am by Dan Hargrove
., Bristol-Myers Squibb Co., GlaxoSmithKline PLC and others that have disclosed investigations for possible FCPA breaches. [read post]
8 May 2012, 6:31 pm by Lawrence B. Ebert
Bristol-Myers Squibb, 246 F.3d at 1376. [read post]
26 Apr 2024, 12:05 pm by admin
Earlier in the winter of 1996, George Gore (Al’s cousin) tried a silicone breast implant case for Bristol Myers Squibb in Oregon state court. [read post]
The Patentees filed two PTE applications, each of which was based on different goods on the ARTG: Brand Name OPDIVO® KEYTRUDA® Active ingredient nivolumab pembrolizumab Australian sponsor Bristol-Myers Squibb Australia Pty Ltd Merck Sharp & Dohme (Australia) Pty Ltd Relationship between sponsor and patentees Related to one of the patentees Not related to either patentee Date goods containing the drug were first included on ARTG 11 January 2016 16 April 2015… [read post]
18 Feb 2011, 11:47 am by Sheppard Mullin
., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
23 Apr 2012, 3:33 am
It also noted that Philipson’s research was supported in part by Bristol-Myers Squibb Co. [read post]
19 Mar 2010, 1:22 am
Solomon, who co-chaired Proskauer's litigation practice until last year, will bring with him a roster of clients, including PepsiCo, Bristol-Myers Squibb and AriZona Iced Tea. [read post]
19 Jun 2017, 12:47 pm by Mark Walsh
Before we can even finish pondering that, Alito is on to his second case, Bristol-Myers Squibb Co. v. [read post]